GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

MGRX · Mar 31, 2026

MANGOCEUTICALS, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001493152-26-024426General Corporate
Operating cash generation8thOwn-history percentile · N=12
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-1932.31% · OPTIONAL · VALID

Revenue growth25thOwn-history percentile · N=8
Evidence method

Yoy · gp.fundamentals.revenue

-37.91% · CORE · VALID

Gross margin0thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.gross_margin

42.73% · CORE · VALID

Operating margin8thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.operating_margin

-4606.75% · CORE · VALID

SBC intensity100thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

1606.32% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History15 statesHistory building
Period transition

What moved in the state?

Cash Generation Decreased
Previous
-1282.89%
Current
-1932.31%
Delta
-649.42%
Growth Decreased
Previous
-25.96%
Current
-37.91%
Delta
-11.96%
Margin Decreased
Previous
54.91%
Current
42.73%
Delta
-12.17%
Profitability Decreased
Previous
-3954.28%
Current
-4606.75%
Delta
-652.47%
Sbc Intensity Increased
Previous
256.19%
Current
1606.32%
Delta
1350.13%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.